Annual Working Capital
$197.34 M
+$99.11 M+100.89%
December 31, 2023
Summary
- As of February 7, 2025, OCUL annual working capital is $197.34 million, with the most recent change of +$99.11 million (+100.89%) on December 31, 2023.
- During the last 3 years, OCUL annual working capital has fallen by -$22.16 million (-10.09%).
- OCUL annual working capital is now -10.09% below its all-time high of $219.50 million, reached on December 31, 2020.
Performance
OCUL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$436.65 M
-$31.96 M-6.82%
September 30, 2024
Summary
- As of February 7, 2025, OCUL quarterly working capital is $436.65 million, with the most recent change of -$31.96 million (-6.82%) on September 30, 2024.
- Over the past year, OCUL quarterly working capital has increased by +$330.46 million (+311.19%).
- OCUL quarterly working capital is now -11.88% below its all-time high of $495.53 million, reached on March 31, 2024.
Performance
OCUL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
OCUL Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +100.9% | +311.2% |
3 y3 years | -10.1% | +144.3% |
5 y5 years | +319.6% | +644.8% |
OCUL Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +100.9% | -11.9% | +538.8% |
5 y | 5-year | -10.1% | +309.9% | -11.9% | +891.5% |
alltime | all time | -10.1% | +1245.0% | -11.9% | +3618.7% |
Ocular Therapeutix Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $436.65 M(-6.8%) |
Jun 2024 | - | $468.61 M(-5.4%) |
Mar 2024 | - | $495.53 M(+151.1%) |
Dec 2023 | $197.34 M(+100.9%) | $197.34 M(+85.8%) |
Sep 2023 | - | $106.19 M(+55.4%) |
Jun 2023 | - | $68.36 M(-11.7%) |
Mar 2023 | - | $77.45 M(-21.2%) |
Dec 2022 | $98.23 M(-40.5%) | $98.23 M(-15.6%) |
Sep 2022 | - | $116.35 M(-13.3%) |
Jun 2022 | - | $134.21 M(-10.9%) |
Mar 2022 | - | $150.69 M(-8.7%) |
Dec 2021 | $164.96 M(-24.8%) | $164.96 M(-7.7%) |
Sep 2021 | - | $178.77 M(-8.3%) |
Jun 2021 | - | $194.97 M(-2.9%) |
Mar 2021 | - | $200.69 M(-8.6%) |
Dec 2020 | $219.50 M(+355.9%) | $219.50 M(+272.0%) |
Sep 2020 | - | $59.00 M(-22.9%) |
Jun 2020 | - | $76.49 M(+73.7%) |
Mar 2020 | - | $44.04 M(-8.5%) |
Dec 2019 | $48.14 M | $48.14 M(-17.9%) |
Sep 2019 | - | $58.63 M(+6.0%) |
Jun 2019 | - | $55.31 M(-21.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $70.56 M(+50.0%) |
Dec 2018 | $47.03 M(+57.2%) | $47.03 M(+4.8%) |
Sep 2018 | - | $44.87 M(-3.7%) |
Jun 2018 | - | $46.57 M(-9.3%) |
Mar 2018 | - | $51.33 M(+71.6%) |
Dec 2017 | $29.91 M(-51.4%) | $29.91 M(-27.9%) |
Sep 2017 | - | $41.51 M(-24.8%) |
Jun 2017 | - | $55.20 M(-26.0%) |
Mar 2017 | - | $74.62 M(+21.1%) |
Dec 2016 | $61.60 M(-39.4%) | $61.60 M(-10.2%) |
Sep 2016 | - | $68.58 M(-12.7%) |
Jun 2016 | - | $78.56 M(-13.8%) |
Mar 2016 | - | $91.09 M(-10.3%) |
Dec 2015 | $101.61 M(+44.5%) | $101.61 M(-3.0%) |
Sep 2015 | - | $104.72 M(-10.5%) |
Jun 2015 | - | $117.05 M(+88.1%) |
Mar 2015 | - | $62.24 M(-11.5%) |
Dec 2014 | $70.31 M(+379.2%) | $70.31 M(-10.9%) |
Sep 2014 | - | $78.89 M(+335.8%) |
Jun 2014 | - | $18.11 M(+54.2%) |
Mar 2014 | - | $11.74 M(-20.0%) |
Dec 2013 | $14.67 M(-29.4%) | $14.67 M |
Dec 2012 | $20.79 M | - |
FAQ
- What is Ocular Therapeutix annual working capital?
- What is the all time high annual working capital for Ocular Therapeutix?
- What is Ocular Therapeutix annual working capital year-on-year change?
- What is Ocular Therapeutix quarterly working capital?
- What is the all time high quarterly working capital for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly working capital year-on-year change?
What is Ocular Therapeutix annual working capital?
The current annual working capital of OCUL is $197.34 M
What is the all time high annual working capital for Ocular Therapeutix?
Ocular Therapeutix all-time high annual working capital is $219.50 M
What is Ocular Therapeutix annual working capital year-on-year change?
Over the past year, OCUL annual working capital has changed by +$99.11 M (+100.89%)
What is Ocular Therapeutix quarterly working capital?
The current quarterly working capital of OCUL is $436.65 M
What is the all time high quarterly working capital for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly working capital is $495.53 M
What is Ocular Therapeutix quarterly working capital year-on-year change?
Over the past year, OCUL quarterly working capital has changed by +$330.46 M (+311.19%)